2023版ESMO临床实践指南:早期乳腺癌的诊断、治疗与随访(上篇) 在2023年12月13日,备受瞩目的《肿瘤学年鉴》(Annals of Oncology,影响因子:50.5)期刊在线发布了2023版ESMO早期乳腺癌临床实践指南——“Early breast cancer: ESMO Clinical Practic...
Park YH, Senkus-Konefka E, Im SA, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Ann ...
The European Guidelines for quality assurance in breast cancer screening and diagnosis recommend performance parameters and indicators that should be monitored in any screening programme []. The European Commission Initiative on Breast Cancer (ECIBC) has produced evidence-based recommendations for ...
参考文献 [1]F. Cardoso et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, Published: 04 June 2019.https://doi.org/10.1093/annonc/mdz173 本文首发:医学界肿瘤频道 本文作者:玉酱 责任编辑:Sharon 版权申明 本文原创 如需转载请...
Clinics dedicated to the assessment and management of early and late treatment side-effects and adherence to treatment and follow-up guidelines should be developed. The management of inflammatory breast cancer in young women should be the same as in the older breast cancer population. Expert opinion...
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 1194, 2019) F Cardoso,S Kyriakides,S Ohno,... - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》 被引量: 0发表: 2021年 Renal cell carcinoma: ESMO ...
[4]Burstein HJ, Curigliano G, Thürlimann B, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021 Oct;32(10):1216-1235. ...
[8]Johnston SRD, Toi M, O'Shaughnessy J, Rastogi P, et al. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet...
2024年欧洲肿瘤内科学会(ESMO)年会/大会将于2024年9月13-17日在西班牙巴塞罗那举行,会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议,每年都有超过30,000名专业人士参加会议;届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂...
1. N. Harbeck, V. Guarneri, J.H. Seo, et al. 93MO Long-term patient-reported outcomes from monarchE: abemaciclib plus endocrine therapy for adjuvant HR+, HER2-, node-positive, high-risk, early breast cancer (EBC) . ABSTRACT BOOK of the ESMO Breast Cancer, 93MO.2023; 8(1S4):1....